# Treatment for Alcohol Dependence With Gabapentin

> **NCT02771925** · PHASE4 · TERMINATED · sponsor: **Dayanand Medical College and Hospital** · enrollment: 25 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** Gabapentin 2g/day divided in two doses for 24 weeks
- **DRUG:** Placebo 2g/day divided in two doses for 24 weeks

## Key facts

- **NCT ID:** NCT02771925
- **Lead sponsor:** Dayanand Medical College and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2018-04-23
- **Final completion:** 2018-05-16
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Due to poor compliance of patients in the study.
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02771925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02771925, "Treatment for Alcohol Dependence With Gabapentin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02771925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*